Page 33 - TD-2-3

Tumor Discovery Targeted drug delivery systems for the treatment of tumors

Formulation and development of transferrin targeted https://doi.org/10.3109/10717544.2015.1055619
solid lipid nanoparticles for breast cancer therapy. Front 109. Mussi SV, Sawant R, Perche F, et al., 2014, Novel
Pharmacol, 11: 614290.
nanostructured lipid carrier co-loaded with doxorubicin
https://doi.org/10.3389/fphar.2020.614290 and docosahexaenoic acid demonstrates enhanced in vitro
activity and overcomes drug resistance in MCF-7/Adr cells.
99. da Rocha MCO, da Silva PB, Radicchi MA, et al., 2020,
Docetaxel-loaded solid lipid nanoparticles prevent tumor Pharm Res, 31: 1882–1892.
growth and lung metastasis of 4T1 murine mammary https://doi.org/10.1007/s11095-013-1290-2
carcinoma cells. J Nanobiotechnology, 18: 43.
110. Wang JY, Song YQ, Peng J, et al., 2020, Nanostructured lipid
https://doi.org/10.1186/s12951-020-00604-7 carriers delivering sorafenib to enhance immunotherapy
induced by doxorubicin for effective esophagus cancer
100. Smith T, Affram K, Nottingham EL, et al., 2020, Application
of smart solid lipid nanoparticles to enhance the efficacy of therapy. ACS Omega, 5: 22840–22846.
5-fluorouracil in the treatment of colorectal cancer. Sci Rep, https://doi.org/10.1021/acsomega.0c02072
10: 16989.
111. Li X, Jia X, Niu H, 2018, Nanostructured lipid carriers
https://doi.org/10.1038/s41598-020-73218-6 co-delivering lapachone and doxorubicin for overcoming
multidrug resistance in breast cancer therapy. Int J
101. Shuhendler AJ, Prasad P, Leung M, et al., 2012, A novel solid
lipid nanoparticle formulation for active targeting to tumor Nanomedicine, 13: 4107–4119.
α (v) β(3) integrin receptors reveals cyclic RGD as a double- https://doi.org/10.2147/IJN.S163929
edged sword. Adv Healthc Mater, 1: 600–608.
112. Liu Q, Li J, Pu G, et al., 2016, Co-delivery of baicalein and
https://doi.org/10.1002/adhm.201200006 doxorubicin by hyaluronic acid decorated nanostructured
lipid carriers for breast cancer therapy. Drug Deliv, 23:
102. Chuang CH, Wu PC, Tsai TH, et al., 2017, Development of
pH-sensitive cationic PEGylated solid lipid nanoparticles 1364–1368.
for selective cancer-targeted therapy. J Biomed Nanotechnol, https://doi.org/10.3109/10717544.2015.1031295
13: 192–203.
113. Li Z, Zou X, Zhu H, et al., 2018, Inhibitory effect of baicalein
https://doi.org/10.1166/jbn.2017.2338 combined with gemcitabine in human pancreatic cancer cell
lines. Oncol Lett, 15: 5459–5464.
103. Wang W, Zhang L, Chen T, et al., 2017, Anticancer effects of
resveratrol-loaded solid lipid nanoparticles on human breast https://doi.org/10.3892/ol.2018.8043
cancer cells. Molecules, 22: 1814.
114. Ni S, Qiu L, Zhang G, et al., 2017, Lymph cancer
https://doi.org/10.3390/molecules22111814 chemotherapy: Delivery of doxorubicin-gemcitabine
prodrug and vincristine by nanostructured lipid carriers. Int
104. Miao J, Du Y, Yuan H, et al., 2015, Improved cytotoxicity of
paclitaxel loaded in nanosized lipid carriers by intracellular J Nanomedicine, 12: 1565–1576.
delivery. J Nanopart Res, 17: 10. https://doi.org/10.2147/IJN.S120685
105. Khosa A, Reddi S, Saha RN, 2018, Nanostructured lipid 115. Ding X, Xu X, Zhao Y, et al., 2017, Tumor targeted
carriers for site-specific drug delivery. Biomed Pharmacother, nanostructured lipid carrier co-delivering paclitaxel and
103: 598–613. indocyanine green for laser triggered synergetic therapy of
cancer. RSC Adv, 7: 35086–35095.
https://doi.org/10.1016/j.biopha.2018.04.055
116. Yang J, Ju Z, Dong S, 2016, Cisplatin and paclitaxel
106. Varshosaz J, Taymouri S, Jahanian-Najafabadi A, et al., 2018,
Efavirenz oral delivery via lipid nanocapsules: Formulation, co-delivered by folate-decorated lipid carriers for the
optimisation, and ex-vivo gut permeation study. IET treatment of head and neck cancer. Drug Deliv, 24: 792–799.
Nanobiotechnol, 12: 795–806. https://doi.org/10.1080/10717544.2016.1236849
https://doi.org/10.1049/iet-nbt.2018.0006 117. Sánchez-López E, Guerra M, Dias-Ferreira J, et al.,
2019, Current applications of nanoemulsions in cancer
107. Zhang XG, Miao J, Dai YQ, et al., 2008, Reversal activity
of nanostructured lipid carriers loading cytotoxic drug in therapeutics. Nanomaterials (Basel), 9: 821.
multi-drug resistant cancer cells. Int J Pharm, 361: 239–244. https://doi.org/10.3390/nano9060821
https://doi.org/10.1016/j.ijpharm.2008.06.002 118. Ganta S, Singh A, Rawal Y, et al., 2016, Formulation
development of a novel targeted theranostic nanoemulsion
108. Wang Y, Zhang H, Hao J, et al., 2016, Lung cancer
combination therapy: Co-delivery of paclitaxel and of docetaxel to overcome multidrug resistance in ovarian
doxorubicin by nanostructured lipid carriers for synergistic cancer. Drug Deliv, 23: 968–980.
effect. Drug Deliv, 23: 1398–1403. https://doi.org/10.3109/10717544.2014.923068

Volume 2 Issue 3 (2023) 27 https://doi.org/10.36922/td.1356